Targeting remyelination: A new chapter in MS therapies?
Ever since disease-modifying therapies emerged onto the scene in the mid-1990s, suppression of damaging inflammation and prevention of the entry of harmful immune…
Multi-million dollar grants announced at ECTRIMS by the International Progressive MS Alliance marks major milestone in progressive MS research
How quickly time flies. A little over a year ago, the MS Society announced the recipients of the International Progressive MS Alliance planning…
World’s brightest minds gather in London for largest MS conference
The MS Society of Canada’s research team has arrived in the vibrant city of London, England to attend the 32nd Congress of the…
MS vaccines: Thinking outside the box for new treatments
At its heart, multiple sclerosis is believed to occur when rogue immune cells attack myelin – a fatty coating that surrounds nerve cells…
Taking a risk: Canadian Bone Marrow Transplantation trial
by Jennifer Molson Still, knowing what I know now, I would do it all over again. I won’t sugar coat this: the trial…
